New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - imipramine hydrochloride 25mg - coated tablet - 25 mg - active: imipramine hydrochloride 25mg excipient: carnauba wax colloidal silicon dioxide copovidone glycerol hypromellose dispersive red isopropyl alcohol lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose povidone purified talc     purified water stearic acid sucrose titanium dioxide   - all forms of depression, including endogenous, organic and psychogenic forms, and depression associated with personality disorders or chronic alcoholism.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - nicorandil, quantity: 20 mg - tablet, uncoated - excipient ingredients: maize starch; stearic acid; mannitol; croscarmellose sodium - ikorel is indicated for the treatment of chronic stable angina pectoris.

United States - English - NLM (National Library of Medicine)

specgx llc - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - imipramine hydrochloride 10 mg - depression – for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. childhood enuresis – may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval sho

United States - English - NLM (National Library of Medicine)

thompson medical solutions llc - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - imipramine hydrochloride 10 mg - depression – for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. childhood enuresis – may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval sho

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - imipramine hydrochloride - tablets - 25 mg milligram

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma-switzerland - coated tablet - 10 mg

Canada - English - Health Canada

novartis pharmaceuticals canada inc - imipramine hydrochloride - tablet - 50mg - imipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

novartis pharmaceuticals canada inc - imipramine hydrochloride - tablet - 25mg - imipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

novartis pharmaceuticals canada inc - imipramine hydrochloride - tablet - 75mg - imipramine hydrochloride 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nicorandil, quantity: 20 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; mannitol; povidone; cetyl alcohol; sodium stearylfumarate - nicorandil is indicated for the treatment of chronic stable angina pectoris.